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ABSTRACT: This article introduces the main relevant aspects of  ehealth or “digital health.” 
In this regard, by way of  an introduction, the concept of  health is addressed. In the second section, 
the core of  this article, different aspects regarding the relationship between health and technology 
(HealthTech) are highlighted. Next, the importance of  technology in order to deliver a preventive 
and personalized medicine, tailor-made to each patient, is addressed. Then, in the fourth section, 
some discriminatory situations that may arise due to not being able to access technology are discussed. 
Finally, I make some remarks regarding the so-called “Internet of  Bodies.”
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1. Introduction. What is “health”?
The term “health” presents two different meanings. First, “health” can mean “the 
state of  complete physical, mental and social well-being and not merely the absence of  disease and 
infirmity.” This definition was developed by the World Health Organization (WHO) in 




“healthcare services” embraces  all  services concerning “healthcare,” that is, “health-related 
services provided by health professionals to patients to assess, maintain or restore their health, including 
the prescription, dispensation and provision of  medicinal products and medical devices” (Art. 3 lit. a 
Directive 2011/24/EU, of  the European Parliament and of  the Council, of  9 March 
2011, on the application patients’ rights in cross-border healthcare2). 
On the other hand, “health services” are excluded from the scope of  application 
of  Directive 2006/123/EC, of  the European Parliament and of  the Council of  12 
December 2006, on services in the Internal Market3 (Art. 2 lit. f). Recital no. 22 of  this 
Directive states that: “The exclusion of  healthcare from the scope of  application of  this Directive 
should cover healthcare and pharmaceutical services provided by health professionals to patients to assess, 
maintain or restore their state of  health where those activities are reserved to regulated health profession 




 2.1. Definition of eHealth
The so-called “eHealth” or “electronic health” has been defined in different ways.4 
At present,  it  is a term that enables the understanding between health professionals 
and the health technology industry.5 The different meanings that have been suggested, 
represent  a  new way  of   thinking,  understanding,  and  living  health  on  the  side  of  
individuals, whether they are citizens, health professionals, or public authorities.6
Electronic health can be defined as the set of  health services provided remotely 
using  information  and  communication  technologies  and  and  Artificial  Intelligence 
(hereinafter, “AI”) systems that are compatible and interoperable.7 In fact, even without 
having  fully  implemented  electronic  health, we  are  already  transcending  it, moving 
1  The  quote  comes  from  the  Preamble  to  the  Constitution  of   the  World  Health  Organization, 
which  was  adopted  by  the  International  Sanitary  Conference,  held  in  New  York  from  June  19 




3 OJ L 376/36, 27.12.2006.
4 Hans Oh et al., “What is eHealth (3): A systematic review of  published definitions”, J Med Internet 
Res, v. 7, no. 1 (2005): e1.
5  eHealth  Taskforce,  “Accelerating  the  development  of   the  eHealth Market  in  Europe”,  eHealth 
Taskforce Report, 2007, 10.
6 Gunther Eysenbach, “What is e-health?”, J Med Internet Res, v. 3, no. 2 (2001): e20.
7  Jelena Madir, “Using technology to deliver health services”,  in HealthTech. Law and Regulation, ed. 
Jelena Madir  (Cheltenham:  Edward  Elgar,  2020),  3;  Juan Alejandro Martínez Navarro, El régimen 
jurídico de la salud electrónica (Tirant lo Blanch: Valencia, 2018), 39.
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towards what we could call “digital health,” in which AI and its different applications will 
have much more weight. This scenario’s benefits permit us to see AI as an essential tool 




application of   technologies  to health  is having:  the first deals with  the cost savings 
(efficiency)  that  these  technologies  mean  for  the  National  Health  Services  without 
diminishing  the quality of   service,11  and  the  second aspect  concerns  the possibility 






his or her own health, in a kind of  peer-to-peer communication with the professional who 
attends him. The use of  the most varied communication and information technologies 










Sept._2020_-_Final_2.pdf. accessed:  February  2021.  See:  Roland  Wiring,  “Artificial  Intelligence  in 
Healthcare”, in HealthTech. Law and Regulation, ed. Jelena Madir (Cheltenham: Edward Elgar, 2020), 144-166.
9 In November 2017, the FDA had approved the first use of  a “digital pill” that communicates from 
the patient’s stomach through sensors to their smartphone or via the internet with the physician. A year 
earlier, the same institution had approved the use of  an “artificial pancreas” [Andrea M. Matwyshyn, 
“The Internet of  Bodies”, Wm. & Mary L. Rev., v. 66, no. 77 (2019): 81-82].
10 COCIR, “Use cases – Artificial Intelligence in Healthcare,” https://www.cocir.org/media-centre/
publications/article/cocir-use-cases-artificial-intelligence-in-healthcare.html, accessed February 2021.
11  In  the  resolution of  WHO, WHA58.28,  it  is  stated  that  “eHealth is the cost-effective and secure use of  
information communication technologies (ICT) in support of  health and health related fields, including healthcare services, 





2015”,  accessed  February  2021, https://www.who.int/publications-detail/atlas-of-ehealth-country-
profiles-the-use-of-ehealth-in-support-of-universal-health-coverage. Also, see: Sojib Bin Zaman et al., 
“Contexts and opportunities of  e-Health technology in Medical Care”, Journal of  Medical Research and 
Innovation, v. 1, no. 2 (2017): AV1-AV.
13 At least this is one of  the purposes of  the European Commission in its Communication regarding 
the achievement of  the digital transformation of  health and care services in the Digital Single Market, the empowerment of  
citizens and the creation of  a healthier society, COM (2018) 233 Final.
14 There are, however, some other concerns that I address in my book: Salud e Inteligencia Artificial desde 
el Derecho Privado (Granada: Comares, 2018), 83-86.
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professionals, who are challenged by emerging technologies (e-learning). Some of  these, 
up to now, have significantly improved their results due to the application of  AI, which 
has allowed, among other aspects, the communication between machines (internet of  




operations. It could be argued that AI application and, particularly, machine learning, in 
the healthcare field, can serve, on the one hand, as a tool that proposes, recommends, 
analyses images, distributes resources, or acts as a second opinion for diagnosis and 
treatment of  diseases with  control remaining with the health professional and, on the 
other hand, as his or her substitute15 such as the image recognition algorithm, which 
can carry out the work currently performed by pathologists and radiologists.
b) The second referred area  includes the electronic  integration of   information 
and distribution systems, both at a regional and national level, including the patient’s 




intermediary platforms, call centers  for citizen assistance  in case of  emergencies or 
administrative procedures related to health carried out electronically and remotely.
c) In relation to the third highlighted area, telemedicine18 and the remote care of  
the patient, who is at home, are crucial.19 Particularly, it handles mobile health (mHealth) 
15 Christian Katzenmeier, “Big Data, E-Health, M-Health, KI und Robotik in der Medizin”, MedR, 
v. 37 (2019): 270; Heinz-Uwe Dettling, “Künstliche Intelligenz und digitale Unterstützung ärtzlicher 
Entscheidungen  in Diagnostik  und  Therapie  -Arzt-  arzneimittel-  und medizinprodukterrechtliche 
Aspekte”, PharmR (2019): 633 et seq.; W. Nicholson Prize II, “Artificial Intelligence in Health Care: 
applications and Legal Implications”, The Scithec Lawyer, v. 14, no. 1 (2017), https://ssrn.com/
abstract=3078704.
16 The EU has established the European Health Data Space, one of  whose aims is to create a standardized 






18 According  to WHO,  telemedicine  is defined as: “the delivery of  healthcare services, where distance is a 
critical factor, by all healthcare professionals using information and communication technologies for the exchange of  
valid information, for diagnosis, treatment and prevention of  disease and injuries, research and evaluation, and for 
the continuing education of  healthcare providers, all in the interests of  advancing the health of  individuals and their 
communities”  (WHO Guidelines,  “Recommendations  on  Digital  Interventions  for  Health  Systems 
Strengthening”, 2019).
19 European Commission, Communication from the Commission to the European Parliament, the 
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using medical (or non-medical) apps, that is, apps for health purposes on smartphones, 
wearables  and  other  devices,  teleconsultation,  teleradiology,  and,  in  general,  remote 
patient monitoring.20 Recently,  remote monitoring of  patients has been used  in  the 
fight  against  COVID-19.  As  an  example,  California-based  start-up  VivaLNK has 
designed  a multifunctional  remote  patient  control  system  together with Alibaba  to 
monitor temperature, electrocardiogram, respiration, heart rate, movement, reducing 
the possibility of  infection for healthcare practitioners who are found in health centers, 
hospitals, or clinics.21
On the other hand, all  the data obtained  in an unstructured way, conveniently 
anonymised and aggregated, are the raw material of  data analysis (Big Data) that, in 
the field of  medicine, has the purpose of  preventing future health risks based, among 
other aspects, on the  individuals’  lifestyle, giving birth to the so-called “predictive and 
preventive medicine.”22  Smart  devices’  data  are  the  raw material  from which AI-based 
systems  with  learning  capability,  analysing  a  large  data  volume,  can  predict  some 
diseases or extract several behavior patterns in relation to, nowadays, COVID-19. They 
can also analyse the results of  experiments that have been carried out in search of  an 
effective vaccine or for the production of  new drugs.23 The importance of  Big data is 
unmatched, for several reasons, due to the speed at which it allows scientists to work 
and to the reduction in time in order to get a diagnosis.24 In this regard, it should be 
mentioned that 5G technology, which provides a technological infrastructure, is more 
than necessary, in times of  COVID-19.
2.2. Approaching mHealth
Electronic health embraces mobile health or mHealth as one of  its poles.25 It can 
be described as the implementation of  digital health services through mobile devices, 
including smartphones, tablets, and other wearables (also called “wearable technology”) such as 
bracelets, glasses,26 footwear or clothing, in which an app is downloaded. Apps are specific 
computer programs that may or may not have a medical or health purpose.27 One of  
the defining features of  mHealth is its “mobility,” that is, the availability, anywhere and 
at any time, of  health data for the user (patient), even for healthcare professionals and 
Council, the European economic and social Committee, and the Committee of  the regions, on 
telemedicine for the benefit of  patients, healthcare systems and society, COM (2008) 689 final.
20 Frederic Vannieuwenborg et al., “Bringing eCare platforms to the market”, Informatics for Health and 
Social Care, v. 42, no. 3 (2017): 207-231.
21  Tony  Bitzionis,  “VivaLNK  Partners  with  Alibaba  on  Remote  Patient  Monitoring  System”, 
FindBiometrics, March 3, 2020, https://findbiometrics.com/biometrics-news-vivalnk-partners-
alibaba-offer-remote-patient-monitoring-system-030301/.
22 Ziad Obermeyer and Ezekiel J. Emanuel, “Predicting the future – Big Data, Machine Learning and 
Clinical Medicine”, N Engl J Med., v. 375, no. 13 (2016): 1216-1219; Alberto Urueña López et al., “Big 
Data en salud digital. Informe de resultados,” RED.ES, accessed February 2021, https://www.ontsi.
red.es/sites/ontsi/files/Informe%20Big%20Data%20en%20Salud%20Digital.pdf.
23 This is the case of  the start-up Insilico Medicine, which, using Artificial Intelligence,  is developing 
molecules  that  allow creating drugs  to fight COVID-19  (see www.insilico.com,  accessed February 
2021).
24 Thus, the start-up Infervision  has  developed  a  tomography  system  using machine  learning  that 
allows detecting the existence of  coronavirus very quickly.
25 Jelena Madir, “Using”, 7-9.
26 Wearables with sensors (VivaLNK) have been used by the Shanghai Public Health Clinical Center to 
combat the spread of  the coronavirus in China.
27  Tom Chakraborti, “Regulation and Governance of  HealthTech”, in HealthTech. Law and Regulation, 
ed.  Jelena Madir (Cheltenham: Edward Elgar, 2020), 26.
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healthcare centers.28 The other characteristic is connectivity. In fact, it is often referred 
to as “connected health,” “wireless health”29 or even “digital health,” one of  its components 




taking of  medicine prescribed by a physician, aiming to help to manage emotions31 or 
apply to fitness (e.g., such as those that measure the steps taken or the daily kilometers 
walked), to our well-being (e.g., the number of  cigarettes smoked) and nutrition. Apps, 
which monitor  the  lifestyle and well-being of   the user or wearer can be connected 
to a health service, or they can possess some sensors that allow the communication 
of  data  to  the health service,  to personalised medical guidance, or enable access  to 
telemedicine throughout a wireless connection.32




of  medical,  public  health,  research,  educational,  economic,  and  social  services,  the 
traceability of  people, or the management of  the health national system quality.34
The WHO has defined the health mobile or mHealth as “medical and public health 
practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital 
assistants (PDAs), and other wireless devices.”35 On its own, in 2014, the EU drew up the 
Green Paper on Mobile Health, where  it carried out an extensive study and established 




is, the specific computer program that we call “app.” In this regard, a distinction should 
be made between those various types of  apps that are installed on smartphones and 
refer to the field of  health, and those apps, which only work on a certain device such as 
a bracelet, a heart rate monitor and that have specific functionality, such as, measuring 
28 Jesús Salido et al., “Desarrollo de Aplicaciones de Salud para dispositivos móviles”, I+S: Informática 
y Salud, no. 110 (2015): 8.




31  Some cases we can bring up:  the emotional management app developed by  the Department of  
Health  of   Catalonia  to  help  during  confinement  due  to  the  pandemic  caused  by  COVID-19 
(GestioEmocional.cat)  and  the okencasa app (www.okencasa.com), the app designed for caregivers 
of  sick people; apps related to mental health (https://www.psycom.net/25-best-mental-health-apps).
32 See more about this topic at: Susana Navas Navarro, “Salud móvil”, in Salud e Inteligencia artificial desde 
el Derecho privado, ed. Susana Navas Navarro (Granada: Comares, 2021), 51-69.
33 This is the case of  the mediktor app (www.mediktor.com).
34 Marcial García Rojo, “mHealth (mobile health)”, I + S Magazine: Informática y Salud, no. 110 (2015): 6.
35 WHO, “mHealth: new horizons for Health through Mobile Technologies: based on the findings 
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the wearers’ heart rate. Moreover, the former or, at least, some of  them, can have a 
health purpose.
The  COVID-19  pandemic  has  meant  a  decisive  push  for  the  advancement 
of  mHealth.  Precisely,  apps are  proving  to  be  useful  in  the  COVID-19  pandemic 
since  they  have  been,  among other  functions,  a way  to  decongest  the  consultation 
and emergency call centers in case of  possible symptoms. Thus, apps like the one set 
up in Singapore, South Korea37 or, Spain – the recent Covid Radar38 – could help 
to prevent new infections by transmitting information about possible symptoms and, 










however, is the collective intelligence.44 Precisely, the appeal to the community and the 
citizens’ collaboration is vital in the fight against COVID-19.
In conclusion, it should be noted, that, at the basis of  any of  these technologies, 
there is an algorithm written in computer language, that is, a computer program, a core 
element for electronic health. Secondly, it should be emphasised that, in a few cases, 
hospitals or healthcare centers, depending on the electronic services they deliver to 
37 Concerning these apps applied in Asia, see: Josep Cañabate Pérez and Albert Castellanos Rodríguez, 
“Análisis de las aplicaciones para seguimientos de contactos COVID-19 en los países de Asia oriental 
a la luz del reglamento General de Protección de datos”, in Salud e Inteligencia artificial desde el Derecho 
privado, ed. Susana Navas Navarro (Granada: Comares, 2021), 217-236.
38  Laura  Sacristán,  “La  app  Radar  COVID  será  compatible  con  otras  aplicaciones  europeas 
próximamente:  el  periodo  de  pruebas  comienza  el  15  de  octubre”,  September  9,  2020,  https://
www.xatakamovil.com/aplicaciones/app-radar-Covid-sera-compatible-otras-aplicaciones-europeas-
proximamente-periodo-pruebas-comienza-15-octubre. 

















44 Don Tapscott  and Anthony D. Williams, Wikinomics. La nueva economía de las multitudes inteligentes 
(Barcelona: Paidós, 2010), 393 et seq.
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patients, can be classified as services providers of  the information society, both in the 
private and public health sector, having to comply with the legislation of  this sector.45
2.3. AI-based systems and Healthcare 
2.3.1. Legislation overview
a) Medical devices
The  EU,  within  its  strategy  for  creating  a  single  Digital  Market,  considers 
electronic health (“eHealth”),  insofar  as  it  intends  to  develop  an  interoperable 
environment, with clear protocols and standards that benefit all stakeholders in health 
services,  including  industry.  Accordingly,  it  published  an  Action  Plan  2012-202046 
and, almost simultaneously, in 2016, the WHO published a report on eHealth for the 




economical  to health; and, finally,  in gradually  implementing high technology in the 
medical-health field aiming at delivering a predictive, precise, and more personalised 
healthcare focusing on the patient.48 
In this regard, one of  the main regulations concerning eHealth is the Regulation 
(EU) 2017/745, of  the European Parliament and of  the Council of  5 April 2017, 




accordance with the Regulation (EU) 2017/745 on medical devices (Art. 2 para. 1), as a 
medical device.52 Indeed, the medical device definition embraces: “any instrument, device, 
45 Directive 2000/31/EC of  the European Parliament and of  the Council of  8 June 2000 on certain 
legal  aspects  of   information  society  services,  particularly  electronic  commerce,  in  the  Internal 
Market (OJ L 178, 17.7.2000) and the prospective Digital Services Act.
46 Communication from the Commission to the European Parliament, the Council, the European 
economic and social committee and the committee of  the regions, eHealth Action Plan 2012-2020 - 
Innovative healthcare for the 21st century, COM (2012) 736 final.
47  This  report  can  be  accessed  at:  http://www.euro.who.int/en/publications/abstracts/from-
innovation-to-implementation-ehealth-in-the-who-european-region-2016.





EU Regulation in the field of  medical devices” in Changes in the Medical Device’s Regulatory Framework 
and its impact on the Medical Device’s industry: from the Medical Device Directives to the Medical Device Regulations 
Erasmus Law Review,  v.  12,  no.  2  (2019):  166-177; Gianluigi  Passarelli,  “Legal  aspects  of   the  path 
towards a true EU Medical Devices innovation”, Le Nuove Leggi Civili Commentate, v. 2 (2020): 309. 
50 About  the concept of  “computer program,”  see: “Guidelines on the qualification and classification of  
stand-alone software used in healthcare within the regulatory framework of  medical devices”  by  the European 
Commission DG  Internal Market,  Industry, Entrepreneurship  and,  SMEs Directorate Consumer, 
Environmental and Health Technologies Unit Health technology and Cosmetics (Meddev 2.1/6, July 
2016): “set of  instructions that processes input data and creates output data”.
51 The Guidelines Meddev 2.1/6 already mentioned defines a “stand-alone-software” as “software which is 
not incorporated in a medical device at the time of  its placing on the market or its making available”.
52 Allison Dennis, “Healthcare Technology Regulation in the EU and the UK: from Medical Devices to 
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equipment, computer program, implant, reagent, material or other article intended by the manufacturer 
to be used in people, separately or in combination, with any of  the following specific medical purposes:
Diagnosis, prevention, monitoring, prediction, prognosis, treatment, or alleviation of  a disease
Diagnosis, monitoring, treatment, alleviation or compensation of  an injury or disability
Investigation, replacement, or modification of  the anatomy or of  a physiological or pathological 
process or state
Obtaining information through the in-vitro examination of  samples from the human body, 









healthcare (e.g., document preparation, medical information storage, word processing), 




certifies the conformity of  this type of  computer program.55 Therefore, the COCIR56 
has  stressed  that  they  cannot  be  placed  on  the market  as  a medical  device.57 The 
Meddev 2.1/6 Guidelines take into particular account the “predetermined” software 
as a paradigm. Even so, the Regulation (EU) on medical devices allows health centers 




safety  and operating  requirements provided  in Annex  I of   the Regulation,  the  rest 
of   the  requirements do not apply. This manufactured  in-house device may well be a 
non-predetermined computer program, which modifies itself  outside or beyond the 
boundaries designed by the manufacturer.
intellectual property and advertising”, in HealthTech. Law and Regulation, ed. Jelena Madir (Cheltenham: 
Edward Elgar, 2020), 59.
53 Armin Gärtner, MEDDEV-Leitfaden 2.1/6 für Software als Medizinprodukt am Beispiel PDMF, 
E-HEALTH.COM.,  2017,  accessed  February  2021,  http://www.e-health-com.eu/fileadmin/user_
upload/dateien/Downloads/ Gaertner_Software_als_Medizinprodukt_end.Pdf.
54 More about computer programs as medical devices in: Susana Navas Navarro, “Salud electrónica e 
Inteligencia Artificial”, in Salud e Inteligencia artificial desde el Derecho privado, ed. Susana Navas Navarro 
(Granada: Comares, 2021), 14-23.
55 See: ISO/IEC WD 22989 Artificial Intelligence. Concepts and Terminology; ISO/IEC WD 23053 
Framework for Artificial Intelligence (AI) Systems Using Machine Learning (ML). Concerning the 
health  software,  see  the  standard:  IEC  82304-1:12016 General  Requirements  for  Product  Safety. 
Online: iso.org. Accessed February 2021.
56 COCIR is the abbreviation for: “The European Coordination Committee of  the Radiological, Electromedical 
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The High-Level Panel of  Experts has, as it is known, been publishing different reports 
on future regulation of  AI. In Ethics Guidelines for Trustworthy,58 Artificial Intelligence refers 
to the “explainability and transparency of  the algorithm” as one of  the properties that make 
an AI system trustworthy. Hopefully these guidelines will be further developed, in the 
future, and the application of  AI to health will be considered from both an ethical and 
legal point of  view.59 This path has already begun with the COCIR Report, in which it 
recommended that the IEC 62304 standard should be studied and, where appropriate, 
updated, requiring manufacturers of  medical devices to establish an “algorithm change 
protocol” (ACP)60 for health products based on AI with learning capability, to establish, 
from the design, minimizing the risk of  bias for vulnerable groups.61
b) High-risk AI-based systems and health
Almost in parallel with the legislation on medical devices, in relation to AI, and 
the huge production of  data, studies, and reports that have been carried out, as well 
as resolutions, communications, and other documents of  the European authorities 
have been published,  relevant working groups have been built up.   Work  is  intense 
within the EU, aiming to produce a future regulation of  AI,62 robotics, and emerging 
technologies, as well as blockchain and online platforms, among others. In addition, 
it  is worth mentioning the forthcoming publication, of  an EU Data Act in 2021, as 
highlighted by the Communication on a European Strategy for Data.63
Particularly, concerning AI, two main reports deserve special attention: firstly, the 
“Liability for Artificial Intelligence and other emerging digital technologies” prepared by the Expert 
Group on Liability and New Technologies – New Technologies Formation, known by the acronym 
NTF, in November 201964 and, secondly, the report from the European Commission 
to the European Parliament, the Council and the European Economic and Social 
Committee, “On the safety and liability implications of  Artificial Intelligence, the Internet of  Things 
and Robotics”65  accompanying  the White paper “On Artificial Intelligence – A European 
approach to excellence and trust.”66 Likewise, two more documents should be mentioned: 
the “Draft Report on Civil Liability Regime for Artificial Intelligence”67 and the “Civil liability 
regime for artificial intelligence” of  the research service of  the European Parliament,68 made 
public in September 2020. Moreover, the “Report with Recommendations to the Commission 





60 Woodraw Barfiled and Ugo Pagallo, Advanced Handbook on Law and Artificial Intelligence (Cheltenham: 









68 See http://www.europal.europa.eu/thinktank, accessed February 2020.
69 2020/2014(INL) 5.10.2020.
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Resolution of  the European Parliament, of  20 October 2020, in which a Proposal for a 
Regulation on civil liability for the operation of  artificial intelligence systems is made.70
On  16  February  2017,  the  European  Parliament  adopted  a  Resolution  on 
“Civil law rules on Robotics”71 with recommendations for the European Commission. 
In this Resolution, the Commission was asked to prepare a proposal for a future legal 
instrument containing civil rules in relation to robots’ liability and other AI systems. 
2018 was  a  very  active  year  in  this  area.72 In March, the Commission founded the 
previously mentioned Expert Group on Liability and New Technologies with two formations: 
NTF (new technologies formation) and PLDF (products liability directive formation). The NTF 
should be limited to the non-contractual liability aspects. After analysing the national 
laws  in  this  regard,  focusing  on  specific  cases,  and  comparing  different  aspects  of  
these  standards,  the  previously  mentioned  report  presented  its  conclusions  and 
recommendations. In addition, in April, the Commission published the Staff  Working 
Document on “Liability for emerging digital technologies”73 accompanied by the document 
“Artificial Intelligence for Europe.”74 
In this contribution, when referring to AI, I considered the definition given by 
the High-level Expert Group on AI,75 established within the EU, such as: “AI systems are 
software (and possibly also hardware) designed by humans that, given a complex objective, act in 
a physical or digital dimension, perceiving their environment through the acquisition of  data, the 
interpretation of  said data, whether structured or not, reasoning, processing the information derived 
from the data and making the best decision to achieve the aforementioned objective.” This definition 
is closely followed by the Resolution of  the European Parliament of  20 October 2020 
(Art. 3 lit. a).76
The medical devices sector is one of  those sectors in which the technology used 
can partly be classified as “high-risk,” using the term suggested by the Resolution of  the 
European Parliament of  20 October 202077 and by the White Paper on Artificial Intelligence. 




72  Actually,  in  February,  the  European  Parliamentary  Research  Service  (EPRS)  published 
additionally the study “A common EU approach to liability rules and insurance for connected and 






disciplines.  Also,  see:  EU  Science  Hub,  JCR  Technical  reports,  “AI  Watch.  Defining  Artificial 









severity of  possible harm or damage, the degree of  autonomy of  decision-making, the likelihood that 
the risk materializes and the manner and the context in which the AI-system is being used”.
78 White Paper, 16-17.
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could affirm that those of  risk class III and IIb would be of  high-risk, while those of  
class IIa and I of  low/medium risk.80
2.3.2. Some controversial issues regarding civil liability
In AI-based systems, there is often more than one person who “operates” the 
technology;  for  example,  the  hospital  or  health  center  that  intervenes  on  a  patient 
with  a  surgical  robot,  but  there  is  also  another  person  or  a  hospital  that  provides 
support services, updates the software, defines the characteristics of  the technology 
or supervises the machine learning system. The first operator is considered, according 
to  the  NTF  and  the  European  Parliament  Resolution  of   October  20,  2020,  as  a 
“frontend operator”81 while the second is viewed as a “backend operator,”82 between 
which a legal relationship may (or may not) exist.83 When an AI-based system is “used” 




cases would not differ  at  all  or  very  little,  for  the purposes of   civil  liability,  of   the 







79 Draft Report, 7.
80 Annex VIII Regulation (UE) 2017/745, on medical devices. See: Tom Chakraborti, “Regulation and 
Governance of  HealthTech”, in HealthTech. Law and Regulation, ed. Jelena Madir (Cheltenham: Edward 
Elgar, 2020), 33.





support  service and  therefore also exercises a degree of  control over  the  risk connected with  the 
operation and functioning of  the AI-system.”
83  See: LiabilityforAIandotheremergingtechnologies.pdf, accessed February 2021.
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who make  the final  decision.  It  is  a  liability by own  action; not,  by  someone  else’s 
behavior.









































the European Parliament, in which recommendations are made to the Commission 
to regulate civil liability for damages caused by operating high-risk AI systems of  20 
84 Ernst Karner, “Liability for robotics: current rules, challenges, and the need for innovative concepts”, 
in Liability for Artificial Intelligence and the Internet of  Things, eds. Sebastian Lohsse, Reiner Schulze and 
Dirk Staudenmayer (Baden Baden: Nomos Verlag, 2018), 120.
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Parliament warns  that “operator”  includes both  front and backend operator, unless 
the  liability of   the  latter  is  already  covered by Directive 85/374/EEC on products 
liability,85 obviously, because he is considered a “producer.”86
3. eHealth and the personalisation of  medicine. Patients 
empowerment
The COVID-19 pandemic is highlighting the importance emerging technologies 
based  on  AI  and  highly  sophisticated  algorithms  as  well  as  the  implantation  of  
communication, information technologies and robotics in different areas of  our life87 
can  become.88  From  personal  relationships  throughout  the  lockdown,  teleworking, 
online training, e-commerce  to,  significant  in  the  current  climate,  “electronic health,” the 
application of  emerging technologies to health will allow the personalisation of  
therapeutical and medical treatments, in relation to the specific individual, that is, the 
healthcare system user.
Technology  and,  particularly,  technology  applied  to  health,  means  that  the 
patient  will  not  be  a mere  passive  subject  regarding  his  own  health.  Rather  he  or 






The term “patient”  should  be  subjected  to  revision.  That  is,  it may  not  serve 
to describe the new citizen interested in his or her health. In fact, the patients’ true 





86 Annabelle Bruyndonckx et al., “Product Liability: compliance and safety issues”, in HealthTech. Law 
and Regulation, ed. Jelena Madir (Cheltenham: Edward Elgar, 2020), 114-142.
87  “What  if   we  could  fight  coronavirus  with  artificial  intelligence”,  EPRS,  European  Parliamentary 
Research Service, Author: Mihalis Kritikos, Scientific Foresight Unit (STOA), PE 641.538, Mach 2020.




study of  seniors in a large health plan”, J Med Internet Res, v. 18, no. 3 (2016): e50.
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(that  is  “nods”),  even  if,  in  practice  in many  cases,  he or  she  is  just  “adhering”  to 
it. A “paternalistic” model continues to prevail (even if  it is “weak”) based more on 
the beneficial  nature of   the medical  profession  than on  the  true  autonomy of   the 
patient,90 although it is intended to present the issue otherwise.91 Technology permits 
responsibility to be shared more equitably between physicians and patients.92
This new approach to individual health gives the possibility of  supplying a more 
personalised medicine, almost tailored to each patient. In this regard, standardisation 
in the health field will gradually disappear to give way to the application of  a much 
more unique medicine, which will have a particular impact on aspects as relevant as the 
informed consent of  the patient/health service user93 and on insurance premiums.94








being deprived of  it and, consequently, of  a certain type of  treatment that could improve 






in  the public and private  sector, with different  functions  (e.g.,  tracking  the contacts 
of  people with a positive diagnosis, entering health data,  locating sick people, etc.), 
and considered one of  the most effective means of  controlling community contagion, 
the elderly have been prevented  from utilising  this means of  disease control.97 The 
exclusion of  this group of  people, to which electronic health comes very late, is clear.
The second social segment I was referring to,  is people with disabilities which 






Revista de Filosofía, II Época, no. 12 (2016): 153-162.
92  EDPS,  Opinion  1/2015,  mHealth.  Online  at:  https://edps.europa.eu/sites/edp/files/
publication/15-05-21_mhealth_en_0.pdf, accessed February 2021.
93 Gunther Eysenbach, “Consumer Health Informatics”, BMJ v. 24, no. 320(7251) (2000): 1713-1716.
94 Carlos Górriz López, “Inteligencia artificial y seguros”, in Salud e Inteligencia artificial desde el Derecho 
privado, ed. Susana Navas Navarro (Granada: Comares, 2021), 269-301.
95  Jelena Madir, “Using”, 2.
96 Eduardo Osuna Carrillo de Albornoz, “La información en el contexto de la atención sanitaria a 
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implies  getting  access  to  a  very  effective  assistive  or  supportive  system  (“assistive 
technology”)98  in order  to overcome social barriers with which  they cope.  In  some 
of   these  cases,  the  exclusion  could  be  alleviated with  a  “universal  design,” making 
the  technology  accessible  to  any  citizen.  The  “universality,”  “inclusivity”  character 
(“design for all”) of  the design, from the conception of  the technology (“by default”), 










Another  situation  that,  in my  view,  should  be  highlighted,  deals with  the  risk 
that  the  data  collected  in  electronic  health  devices will  be  crossed with  other  data 
(for  example,  that  extracted  from  user  interaction  on  social  networks),  allowing 
the  creation  of   profiles,  which  lead  to  automated  decision-making  harming  users 
significantly.  While  Art.  22  General  Data  Protection  Regulation100 requires that 
the “owner” of   the data  should be  informed about  the computational  logic  that  is 
being used, the truth is, in practice, it can generate invisible discrimination related to 
health,  for  instance,  concerning  a  disease  suffered  by  an  individual  (e.g., AIDS)  or 
regarding his or her disability. These situations can be direct discrimination, but they 
can also be discrimination by association,101 such as when a person is discriminated 
against for having a child with a disability, caring for a terminally ill person or infected 
with COVID-19. In these cases, there is most likely a gender bias102 also, leading to a 
“double discrimination,” which  is usually “invisible”103 for the person discriminated 
against. Thus,  it  is  extraordinarily  important  the  segregation,  in general, of  data by 
sex and, particularly, in the medical field, to the extent that men and women may react 
differently to treatment due to their not always identical physiology.104
98 Directive  (EU)  2019/882,  of   the  European  Parliament  and  of   the  Council  of   04.17.2019,  on 
the accessibility requirements of  goods, products and services (OJ L 151/170, 7.6.2019) defines the 
“technology support” (Art. 3 nr. 37) as follows: “any item, equipment, service or product system, including 
programs, that is used to increase, maintain, replace or improve the functional capacities of  people with disability, or to 
alleviate or compensate for deficiencies, activity limitations or participation restrictions.”
99 The Convention on the rights of  persons with disabilities, signed in New York on December 13, 
2002, (https://www.un.org/en/, accessed February 2021) defines “universal design,” in Art. 2, as “the 
design of  products, environments, programs and services to be usable by all people, to the greatest extent possible, without 
the need for adaptation or specialized design”. “Universal  design”  shall  not  exclude  assistive  devices  for 
particular groups of  persons with disabilities where is needed.
100 Regulation (EU) 2016/679 (General Data Protection Regulation) in the current version of  the OJ 
L 119, 04.05.2016; cor. OJ L 127, 23.5.2018.
101 Sandra Watcher and Brent Mittelstadt, “A right to reasonable inferences: re-thinking data protection 
law in the Age of  Big Data and AI”, Columbia Business Law Review, v. 2 (2019): 494 et seq.
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5. Conclusion. Internet of  bodies
The technology applied to health and, particularly, that related to medical devices 
leads to the “Internet of  Medical Things”105 (IoMT), which is linked to the so-called “Internet 
of  Bodies” (IoB).106 When  the device connected  to  the human body  is of  a medical 
nature, both IoMT and IoB, in the end, involve “quantifying,” that is, human beings 









us, whether online or offline, we are asked for a score. We are becoming a society of  
quantification.109 The problem is that, although numerical data can give a clearer vision 
of  reality, they also simplify it and can do so to a point where a new reality is built. In 
short, it is used as a social engineering tool. In the case that I address – the IoB – the 




“personalise” is a common feature of  this time.111 Therefore, all this amount of  data, 
massively  analysed,  can drive  to developing and publishing  tailor-made  legal norms 
(norms’ “personalization”) or, at least, to the personalised “application” of  the existing 
legal  norm(s)  decided  by  an  algorithm. Hence,  it must  be  noted  that  the  decision 
adopted  cannot  significantly  harm  the  holder  of   the  data  (arg. ex Art. 22 GDPR), 
especially in the absence of  his or her consent. 
Generalitat de Catalunya, 2020).
105  Florence  Hudson  and  Chris  Clark,  “Wearables  and  Medical  Interoperability:  The  Evolving 
Frontier”, Computer, v. 51, no. 9 (2018): 86-90.
106 Andrea M. Matwyshyn, “The Internet of  Bodies”, 81-82.
107 Three generations of   technologies  related  to  the human body are already mentioned. The first 
generation consists of  external technology such as wearables that we have reported in this work. The 
second one deals with technology implanted in the human body, such as an artificial pancreas or a 
cochlear implant. The third has to do with the fusion of  the human mind with computers and the 
Internet, which is known as “brain-computer interface” (BCI). About this and other issues, see: Andrea 
M. Matwyshyn, “The Internet of  Bodies”, 94-115.
108 Steffen Mau, The Metric Society (Cambridge: Polity Press, 2019), 99 et seq.
109 Steffen Mau, The Metric Society, 10 et seq.
110 Susana Navas Navarro and Sandra Camacho Clavijo, El ciborg humano. Aspectos jurídicos (Granada: 
Comares, 2018).
111 Andreas Reckwitz, Die Gesellschaft der Singularitäten (Berlin: Suhrkamp, 2ond ed., 2020), 27 et seq.
